Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 3482.00, up by 47.90 points or 1.39 % from its previous closing of Rs. 3434.10 on the BSE.

The scrip opened at Rs. 3440.00 and has touched a high and low of Rs. 3482.50 and Rs. 3373.00 respectively. So far 7467 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3662.00 on 01-Dec-2014 and a 52 week low of Rs. 2250.00 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 3513.20 and Rs. 3370.00 respectively. The current market cap of the company is Rs. 59185.66 crore.

The promoters holding in the company stood at 25.49 % while Institutions and Non-Institutions held 44.19 % and 12.91 % respectively.

Dr Reddy's Laboratories has established a new formulation development laboratory at its facility in Miyapur in Hyderabad. This was part of expansion of its existing custom service facilities.

Following this expansion, the laboratories will form a centre of excellence for fully integrated active pharmaceutical ingredients (APIs) and formulation development services, including pre-formulation studies, prototype formulation development, process development and optimisation.

Dr Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.